Shree Pacetronix Ltd operates in Medical Equipment & Supplies within the Healthcare sector.
1,328 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | 65.2% | 65.4% | 65.8% | 66.7% | 67% | 70.4% |
| EBITDA margin % | 10.3% | 14% | 14.7% | 17.7% | 26.9% | 25.7% | 13.1% | 23.5% |
| EBIT margin % | 5.1% | 8.2% | 7.9% | 12.2% | 23.8% | 22% | 8.9% | 20.1% |
| PAT margin % | 1.9% | 3.2% | 2.4% | 7.2% | 16.1% | 15.3% | 4.5% | 14% |
| Working capital | ||||||||
| Receivable days | — | — | 195 | 210 | 109 | 96 | 165 | 179 |
| Inventory days | — | — | 272 | 194 | 157 | 286 | 463 | 275 |
| Payable days | — | — | 47 | 18 | 32 | 12 | 57 | 70 |
| NWC days | — | — | 419 | 386 | 234 | 370 | 571 | 385 |
| Leverage | ||||||||
| Current ratio | — | — | 1.64 | 1.67 | 1.87 | 1.99 | 2.07 | 2.69 |
| Debt to EBITDA | — | — | 2.47 | 1.79 | 0.4 | 0.75 | 2.26 | 0.51 |
| Debt to equity | — | — | 0.46 | 0.44 | 0.22 | 0.32 | 0.36 | 0.14 |
| Interest coverage | 1.8 | 2.1 | 1.9 | 4.1 | 16.3 | 13.9 | 2.8 | 11.5 |
| Asset turnover | — | — | 0.71 | 0.75 | 1.22 | 1.01 | 0.73 | 0.84 |
| Return ratios | ||||||||
| Return on assets % | — | — | 1.7% | 5.4% | 19.6% | 15.4% | 3.3% | 11.7% |
| Return on capital employed % | — | — | 10.1% | 17.1% | 56.6% | 41.8% | 11.6% | 27.4% |
| Return on equity % | — | — | 3.1% | 9.9% | 33.2% | 25.5% | 5.4% | 16.7% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Shree Pacetronix Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.25% | 24.25% | 24.25% | 24.25% | 24.25% | 24.25% | 24.25% | 24.25% | 24.25% | 25.8% | 31.7% | 36.44% | |
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.14% | 0.14% | 0% | 0% | |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 75.75% | 75.75% | 75.75% | 75.75% | 75.75% | 75.75% | 75.75% | 75.75% | 75.61% | 74.06% | 68.3% | 63.56% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 6,665 | 6,529 | 6,567 | 6,615 |
Promoter holding up 12.19 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 29 Jun 2026 | TASNEEM KHAMBATY | Bulk | BSE | Sell | 20,250 | ₹124.69 | ₹0.25 Cr |
| 29 Jun 2026 | PRATYUSH MITTAL | Bulk | BSE | Buy | 18,773 | ₹125.54 | ₹0.24 Cr |
| 8 Jan 2026 | SANJAY PHULCHAND KULAR | Bulk | BSE | Sell | 19,000 | ₹165.91 | ₹0.32 Cr |
| 5 Jan 2026 | AMIT KUMAR | Bulk | BSE | Sell | 20,653 | ₹156.71 | ₹0.32 Cr |
| 30 Dec 2025 | DHEERAJ KUMAR LOHIA | Bulk | BSE | Buy | 24,000 | ₹182.90 | ₹0.44 Cr |
| 30 Dec 2025 | SANJAY PHULCHAND KULAR | Bulk | BSE | Sell | 23,805 | ₹182.90 | ₹0.44 Cr |
| 29 Dec 2025 | SANJAY PHULCHAND KULAR | Bulk | BSE | Sell | 20,647 | ₹192.57 | ₹0.40 Cr |
| 22 Dec 2025 | ABHISHEK SINGHVI | Bulk | BSE | Sell | 25,510 | ₹203.74 | ₹0.52 Cr |
| 12 Dec 2025 | SANJAY PHULCHAND KULAR | Bulk | BSE | Buy | 45,920 | ₹265.20 | ₹1.22 Cr |
| 12 Dec 2025 | SANJAY PHULCHAND KULAR | Bulk | BSE | Sell | 2,509 | ₹261.73 | ₹0.07 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Board Meeting Intimation for Intimation Of BM (01St/2026-2027) Of The Com. Under Reg. 29(1) And (2) Of SEBI (LODR) Regulation 2015 To Inter-Alia, Consider And Approve The Standalone & Consolidated Audited FR For The Quarter And Financial Year Ended 31.03.2026
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnostics LimitedMOLBIOMOLBIO | ₹17,431 Cr | ₹17,844 Cr | ₹1,020 Cr | ₹262 Cr | 25.7% | ₹145 Cr | 13.6% | 23.7% | 16.2% | — |
| Poly Medicure LimitedPOLYMEDPOLYMED | ₹16,610 Cr | ₹16,952 Cr | ₹1,997 Cr | ₹461 Cr | 23.6% | ₹315 Cr | 17.1% | 14.5% | 11% | 294 |
| Fischer Medical Ventures LimitedFISCHERFISCHER | ₹2,190 Cr | ₹2,262 Cr | ₹367 Cr | ₹50 Cr | 14% | ₹30 Cr | 10.1% | 13.6% | 8.6% | 111 |
| Tarsons Products LimitedTARSONSTARSONS | ₹1,752 Cr | ₹2,135 Cr | ₹441 Cr | ₹119 Cr | 27.9% | ₹11 Cr | 3.4% | 5% | 2.3% | 361 |
| Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL | ₹1,066 Cr | ₹1,066 Cr | ₹287 Cr | ₹46 Cr | 15.6% | ₹31 Cr | 10.4% | 14.7% | 12.8% | 109 |
| Hemant Surgical Industries LtdHSILHSIL | ₹885 Cr | — | ₹232 Cr | ₹23 Cr | 10% | ₹18 Cr | 7.9% | — | — | — |
| Fabtech Technologies LimitedFABTECHFABTECH | ₹632 Cr | ₹675 Cr | ₹418 Cr | ₹45 Cr | 8.5% | ₹49 Cr | 9.3% | 15.5% | 12.9% | 55 |
| Prevest Denpro LtdPREVESTPREVEST | ₹452 Cr | — | ₹72 Cr | ₹25 Cr | 34.4% | ₹20 Cr | 28.5% | — | — | — |
| Nureca LimitedNURECANURECA | ₹332 Cr | ₹333 Cr | ₹153 Cr | ₹4 Cr | 0.1% | ₹4 Cr | 1.4% | 3.3% | 1.1% | 186 |
| Earkart LtdEARKARTEARKART | ₹179 Cr | ₹179 Cr | ₹54 Cr | ₹8 Cr | 15.5% | ₹5 Cr | 9.1% | 12.1% | 7.7% | 243 |
| Choksi Asia LtdCHOKSICHOKSI | ₹117 Cr | ₹119 Cr | ₹11 Cr | ₹-2 Cr | 13.8% | ₹2 Cr | 10.8% | 18.9% | 13.5% | 142 |
| Shree Pacetronix LtdSHREEPACSHREEPAC | ₹68 Cr | ₹71 Cr | ₹8 Cr | ₹1 Cr | 23.5% | ₹0 Cr | 14% | 27.4% | 18.9% | 385 |
Documents link to external sources (exchange filings, company investor pages).
Intimation Of Receipt Of Trading Approval For 75,150 Equity Shares Of Rs.10/- Each Issued At Premium Of Rs. 71/- Bearing Distinctive Numbers From 3674551 To 3749700 Issued To Promoter On A Preferential Basis Pursuant To Conversion Of Warrants.
Intimation Of Approval Received For Listing Of 75150 Equity Shares Of Rs. 10/- Each Issued At Premium Of Rs. 71/- Issued To Promoter On Preferential Basis Pursuant To Conversion Of Warrant
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Announcement under Regulation 30 (LODR)-Newspaper Publication
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Reply To Clarification On Price Movement Sought By BSE Limited Dated 09.04.2026
Clarification sought from Shree Pacetronix Ltd
| Date | Category | Subject | Filing |
|---|---|---|---|
| 16 May 2026, 2:11 pm | Board Meeting | Board Meeting Intimation for Intimation Of BM (01St/2026-2027) Of The Com. Under Reg. 29(1) And (2) Of SEBI (LODR) Regulation 2015 To Inter-Alia, Consider And Approve The Standalone & Consolidated Audited FR For The Quarter And Financial Year Ended 31.03.2026 | |
| 15 May 2026, 2:11 pm | Company Update General | Intimation Of Receipt Of Trading Approval For 75,150 Equity Shares Of Rs.10/- Each Issued At Premium Of Rs. 71/- Bearing Distinctive Numbers From 3674551 To 3749700 Issued To Promoter On A Preferential Basis Pursuant To Conversion Of Warrants. | |
| 7 May 2026, 6:48 pm | Company Update General | Intimation Of Approval Received For Listing Of 75150 Equity Shares Of Rs. 10/- Each Issued At Premium Of Rs. 71/- Issued To Promoter On Preferential Basis Pursuant To Conversion Of Warrant | |
| 30 Apr 2026, 4:28 pm | Others Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | |
| 30 Apr 2026, 4:08 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication | |
| 10 Apr 2026, 4:56 pm | Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| 10 Apr 2026, 1:15 pm | Company Update General | Reply To Clarification On Price Movement Sought By BSE Limited Dated 09.04.2026 | |
| 10 Apr 2026, 8:42 am | Company Update Clarification | Clarification sought from Shree Pacetronix Ltd | — |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 7 | 7 | 7 | 9 | 8 | 9 | 20 | 22 | 17 | 22 | |
| COGS | -3 | -3 | -3 | -3 | -3 | 3 | 3 | 7 | 7 | 6 | 6 |
| Gross profit | — | — | — | — | — | 5 | 6 | 13 | 15 | 11 | 15 |
| 10 | 9 | 9 | 10 | 11 | 4 | 4 | 8 | 9 | 9 | 10 | |
| 0 | 0 | 1 | 1 | 1 | 1 | 2 | 5 | 6 | 2 | 5 | |
| OPM % | 5.5% | 0.9% | 12.3% | 10.3% | 14% | 14.7% | 17.7% | 26.9% | 25.7% | 13.1% | 23.5% |
| Depreciation | — | — | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | 0 | -0 | 0 | 0 | 0 | 0 | 1 | 5 | 5 | 1 | 4 |
| Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
| Tax % | 114.3% | -27.5% | 45.5% | 41.7% | 34.2% | 41.9% | 26.1% | 29.4% | 27.3% | 27.9% | 26.2% |
| 0 | -0 | 0 | 0 | 0 | 0 | 1 | 3 | 3 | 1 | 3 | |
| PAT margin % | 0% | -4.2% | 1.2% | 1.9% | 3.2% | 2.4% | 7.2% | 16.1% | 15.3% | 4.5% | 14% |
| EPS (₹) | -0 | -0.8 | 0.3 | 0.4 | 0.8 | 0.5 | 1.8 | 9 | — | — | 8.3 |
| EPS adjusted (₹) | — | — | — | — | — | 0.5 | 1.8 | 9 | 9.3 | 2.1 | 8.1 |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 2 | 3 | 6 | 10 | 10 | 14 |
| 3 | 3 | 2 | 4 | 5 | 3 | |
| 2 | 3 | 5 | 4 | 4 | 5 | |
| Total equity & liabilities | 11 | 12 | 17 | 22 | 23 | 26 |
| 3 | 3 | 3 | 4 | 3 | 4 | |
| CWIP | — | 0 | 0 | — | — | 1 |
| Investments | 1 | 1 | 1 | 1 | 1 | 1 |
| 7 | 9 | 13 | 17 | 19 | 21 | |
| Total assets | 11 | 12 | 17 | 22 | 23 | 26 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 1 | 1 | 2 | -0 | 0 | 4 | |
| -1 | -1 | -1 | -2 | -0 | -2 | |
| -0 | -0 | -1 | 2 | 0 | -1 | |
| Net cash flow | 0 | -1 | 0 | 0 | 0 | 1 |
| Free cash flow | 0 | 0 | 1 | -1 | -1 | 4 |
| CFO / Operating profit % | 89.2% | 36.9% | 45% | -0.5% | 2.3% | 76% |